Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab
Abstract
Authors
S Tempelaar S Stephens J Schouten
S Tempelaar S Stephens J Schouten
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now